Thabor Therapeutics Develops innovative treatments for mucosal inflammatory diseases
Business Model:
Revenue: $12.2k
Employees: 2-10
Address: -
City: Paris
State: île-de-france
Zip: 75001
Country: FR
Thabor is a France-based biotechnology company that researches and commercializes novel drugs for the treatment of mucosal inflammatory diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2022 | Seed Round | 1 | $2M |
Bpifrance Bpifrance |
1/2021 | Seed Round | - |
AdBio partners AdBio partners |
7/2022 | Equity | $2.1M |
Bpifrance |
1/2021 | Seed Round | 1 | - |
AdBio partners AdBio partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|